Correlation Between Visa and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Visa and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Purple Biotech, you can compare the effects of market volatilities on Visa and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Purple Biotech.
Diversification Opportunities for Visa and Purple Biotech
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Purple is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Visa i.e., Visa and Purple Biotech go up and down completely randomly.
Pair Corralation between Visa and Purple Biotech
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.18 times more return on investment than Purple Biotech. However, Visa Class A is 5.46 times less risky than Purple Biotech. It trades about 0.08 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.07 per unit of risk. If you would invest 21,128 in Visa Class A on September 2, 2024 and sell it today you would earn a total of 10,380 from holding Visa Class A or generate 49.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 78.02% |
Values | Daily Returns |
Visa Class A vs. Purple Biotech
Performance |
Timeline |
Visa Class A |
Purple Biotech |
Visa and Purple Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Purple Biotech
The main advantage of trading using opposite Visa and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
Purple Biotech vs. Bezeq Israeli Telecommunication | Purple Biotech vs. Brainsway | Purple Biotech vs. Mivne Real Estate | Purple Biotech vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |